Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1927 1
1928 1
1945 3
1946 1
1947 1
1948 5
1949 4
1950 3
1951 3
1952 2
1953 5
1954 3
1955 10
1956 3
1957 8
1958 6
1959 7
1960 10
1961 5
1962 3
1963 6
1964 3
1965 1
1966 6
1967 6
1968 6
1969 6
1970 5
1971 5
1972 4
1973 4
1974 6
1975 10
1976 10
1977 7
1978 7
1979 6
1980 10
1981 13
1982 4
1983 13
1984 7
1985 15
1986 18
1987 15
1988 20
1989 18
1990 22
1991 31
1992 23
1993 21
1994 24
1995 31
1996 33
1997 29
1998 28
1999 25
2000 30
2001 22
2002 22
2003 32
2004 23
2005 35
2006 30
2007 37
2008 35
2009 36
2010 46
2011 53
2012 43
2013 45
2014 53
2015 52
2016 45
2017 49
2018 41
2019 45
2020 54
2021 52
2022 48
2023 51
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

1,471 results

Results by year

Filters applied: . Clear all
Page 1
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial.
Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, Jódar E, Kandler K, Rigas G, Wadden TA, Wharton S; STEP 5 Study Group. Garvey WT, et al. Among authors: christensen ln. Nat Med. 2022 Oct;28(10):2083-2091. doi: 10.1038/s41591-022-02026-4. Epub 2022 Oct 10. Nat Med. 2022. PMID: 36216945 Free PMC article. Clinical Trial.
Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype.
Kosiborod MN, Abildstrøm SZ, Borlaug BA, Butler J, Christensen L, Davies M, Hovingh KG, Kitzman DW, Lindegaard ML, Møller DV, Shah SJ, Treppendahl MB, Verma S, Petrie MC. Kosiborod MN, et al. Among authors: christensen l. JACC Heart Fail. 2023 Aug;11(8 Pt 1):1000-1010. doi: 10.1016/j.jchf.2023.05.010. Epub 2023 May 21. JACC Heart Fail. 2023. PMID: 37294245 Free article. Clinical Trial.
European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack.
Dawson J, Béjot Y, Christensen LM, De Marchis GM, Dichgans M, Hagberg G, Heldner MR, Milionis H, Li L, Pezzella FR, Taylor Rowan M, Tiu C, Webb A. Dawson J, et al. Among authors: christensen lm. Eur Stroke J. 2022 Sep;7(3):I-II. doi: 10.1177/23969873221100032. Epub 2022 Jun 3. Eur Stroke J. 2022. PMID: 36082250 Free PMC article.
Diets, nutrients, genes and the microbiome: recent advances in personalised nutrition.
Matusheski NV, Caffrey A, Christensen L, Mezgec S, Surendran S, Hjorth MF, McNulty H, Pentieva K, Roager HM, Seljak BK, Vimaleswaran KS, Remmers M, Péter S. Matusheski NV, et al. Among authors: christensen l. Br J Nutr. 2021 Nov 28;126(10):1489-1497. doi: 10.1017/S0007114521000374. Epub 2021 Jan 29. Br J Nutr. 2021. PMID: 33509307 Free PMC article. Review.
Use and development of contraceptive apps.
Christensen LD, Lauszus FF, Ravn P. Christensen LD, et al. Ugeskr Laeger. 2023 Jan 2;185(1):V04220288. Ugeskr Laeger. 2023. PMID: 36629292 Free article. Danish.
1,471 results